Coloplast CEO says no sign of recovery in China
China remains a large obstacle for Coloplast, which is feeling the effect of the country’s hardline stance Covid-19 policy on growth.
by marketwire, translated by jonas sahl hollænder
Several divisions of Coloplast remained negatively affected by China’s lockdowns in Q4, with authorities still upholding a hardline policy on Covid-19 outbreaks.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast playing it safe with new guidance due to inflation
For subscribers
